The prognostic and diagnostic significance of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2018) Peter R. Galle et al.   JOURNAL OF HEPATOLOGY

Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients

(2018) Yann-Alexandre Vano et al.   PLoS One

Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies

(2017) Jordi Bruix et al.   JOURNAL OF HEPATOLOGY

Neutrophil-to-lymphocyte ratio predicts survival in European patients with hepatocellular carcinoma administered sorafenib

(2017) Alberto Lué et al.   Oncotarget

Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies

(2016) Xingshun Qi et al.   Oncotarget

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis

(2014) Arnoud J. Templeton et al.   JNCI-Journal of the National Cancer Institute

Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: A Western perspective

(2013) Kevin M. Sullivan et al.   JOURNAL OF SURGICAL ONCOLOGY

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies

(2009) Puneeta Tandon et al.   LIVER INTERNATIONAL